The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Withanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)‐induced neurodegeneration
Abstract
At the present, medication of dementia is limited to symptomatic treatments such as the use of cholinesterase inhibitors. To cure dementia completely, that is regaining neuronal function, reconstruction of neuronal networks is necessary. Therefore, we have been exploring antidementia drugs based on reconstructing neuronal networks in the damaged brain and found that withanoside IV (a constituent of Ashwagandha; the root of Withania somnifera) induced neurite outgrowth in cultured rat cortical neurons. Oral administration of withanoside IV (10 micromol/kg/day) significantly improved memory deficits in Abeta(25-35)-injected (25 nmol, i.c.v.) mice and prevented loss of axons, dendrites, and synapses. Sominone, an aglycone of withanoside IV, was identified as the main metabolite after oral administration of withanoside IV. Sominone (1 microM) induced axonal and dendritic regeneration and synaptic reconstruction significantly in cultured rat cortical neurons damaged by 10 microM Abeta(25-35). These data suggest that orally administrated withanoside IV may ameliorate neuronal dysfunction in Alzheimer's disease and that the active principle after metabolism is sominone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various CNS active Indian herbal medicines like Withania somnifera, Centella asiatica, Celastrus paniculatus and Bacopa monnieri have shown cognitive improvement in experimental models of AD when given as prophylactic treatment [43,44,45,46,47,48].”
From Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment (2020) · cites this paper as [44]
In the citing paper
“Withanoside IV, another chemical constituent of Withania, when administered orally at the dose of 10 micromol/kg prevented cognitive impairment in the experimental model of AD [44].”
From Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment (2020) · cites this paper as [44]
In the citing paper
“Sominone (1 microM) a metabolite of Withanoside IV, induced axonal and dendritic regeneration and synaptic reconstruction in cultures of rat cortical neurons damaged by the amyloid peptide, Aβ(25–35) [44].”
From Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment (2020) · cites this paper as [44]
In the citing paper
“Withaferin-A extracted from WS (1.882 µg per mouse) could inhibit phorbol-12-myristate 13-acetate (PMA)-induced [Endothelial protein C receptor (EPCR)] shedding by the inhibition of TNF-α and Interleukine (IL)-1b in Human Umbilical Vein Endothelial Cell lines (HUVECs) by inactivating tumor necrosis factor-α converting enzyme (TACE).”
From Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects (2021) · cites this paper as [164]
In the citing paper
“Inhibited TNF-α and IL-1b”
From Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects (2021) · cites this paper as [164]
Citations
Cites
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Pike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699
Maurice, T., Lockhart, B. P., & Privat, A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01032-7 · Cited by 530
Reversible memory loss in a mouse transgenic model of Alzheimer’s disease
Kotilinek, L. A., Bacskai, B., Westerman, M., Kawarabayashi, T., Younkin, L., Hyman, B. T., Younkin, S., & Ashe, K. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06331.2002 · Cited by 420
Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I. M., Becker, G. W., & Brems, D. N. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10007-2 · Cited by 371
Neuritic regeneration and synaptic reconstruction induced by withanolide A
Kuboyama, T., Tohda, C., & Komatsu, K. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706122 · Cited by 339
Self-citationSearch for natural products related to regeneration of the neuronal network
Tohda, C., Kuboyama, T., & Komatsu, K. (2005) · Neurosignals · doi:10.1159/000085384 · Cited by 257
Self-citationKnowles, R. B., Wyart, C., Buldyrev, S. V., Cruz, L., Urbanc, B., Hasselmo, M. E., Stanley, H. E., & Hyman, B. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5274 · Cited by 241
BOBINSKI, M., WEGIEL, J., TARNAWSKI, M., BOBINSKI, M., REISBERG, B., DE LEON, M. J., MILLER, D. C., & WISNIEWSKI, H. M. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00010 · Cited by 208 · cited 4×
“present in two cortical regions (parietal cortex and temporal cortex) and in two hippocampal regions (CA1 and CA3) in patients with Alzheimer’s disease (DeKosky & Scheff, 1990; Bobinski et al., 1997) and in mouse models of Alzheimer’s disease (Games et al.”
BackgroundInfluentialWithanolide Derivatives from the Roots of Withania somnifera and Their Neurite Outgrowth Activities.
Zhao, J., Nakamura, N., Hattori, M., Kuboyama, T., Tohda, C., & Komatsu, K. (2002) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.50.760 · Cited by 194
Self-citationAnimal models of Alzheimer's disease and evaluation of anti-dementia drugs
Yamada, K., & Nabeshima, T. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00081-4 · Cited by 192
Akao, T., Kanaoka, M., & Kobashi, K. (1998) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.21.245 · Cited by 189
Senile plaques as aberrant sprout-stimulating structures
Geddes, J. W., Anderson, K. J., & Cotman, C. W. (1986) · Experimental Neurology · doi:10.1016/0014-4886(86)90254-2 · Cited by 162
Grace, E. A., Rabiner, C. A., & Busciglio, J. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00241-5 · Cited by 153
β-Amyloid of Alzheimer's Disease Induces Reactive Gliosis That Inhibits Axonal Outgrowth
Canning, D. R., McKeon, R. J., DeWitt, D. A., Perry, G. L., Wujek, J. R., Frederickson, R. C. A., & Silver, J. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1199 · Cited by 147
Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha
Kuboyama, T., Tohda, C., Zhao, J., Nakamura, N., Hattori, M., & Komatsu, K. (2002) · Neuroreport · doi:10.1097/00001756-200210070-00005 · Cited by 146
Self-citationTohda, C., Matsumoto, N., Zou, K., Meselhy, M. R., & Komatsu, K. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300388 · Cited by 142
Self-citationNeurotrophic and Neuroprotective Actions of Ginsenosides Rb1 and Rg1
Rudakewich, M., Ba, F., & Benishin, C. G. (2001) · Planta Medica · doi:10.1055/s-2001-16488 · Cited by 124
Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK-N-SH cells
Tohda, C., Kuboyama, T., & Komatsu, K. (2000) · Neuroreport · doi:10.1097/00001756-200006260-00035 · Cited by 109
Self-citationAkao, T., Hayashi, T., Kobashi, K., Kanaoka, M., Kato, H., Kobayashi, M., Takeda, S., & Oyama, T. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03756.x · Cited by 100
Yamazaki, M., Chiba, K., Mohri, T., & Hatanaka, H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00533.x · Cited by 72
Dammarane-Type Saponins from Panax japonicus and Their Neurite Outgrowth Activity in SK-N-SH Cells
Zou, K., Zhu, S., Meselhy, M. R., Tohda, C., Cai, S., & Komatsu, K. (2002) · Journal of Natural Products · doi:10.1021/np0201117 · Cited by 61
Self-citationTohda, C., Tamura, T., & Komatsu, K. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03449-8 · Cited by 56
Self-citationNardosinone, a novel enhancer of nerve growth factor in neurite outgrowth from PC12D cells
Li, P., Matsunaga, K., Yamamoto, K., Yoshikawa, R., Kawashima, K., & Ohizumi, Y. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00629-1 · Cited by 47
Effect of Paeoniflorin, Glycyrrhizin and Glycyrrhetic acid on Ovarian Androgen Production
Takeuchi, T., Nishii, O., Okamura, T., & Yaginuma, T. (1991) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x91000119 · Cited by 47
Li, P., Matsunaga, K., Yamakuni, T., & Ohizumi, Y. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01949-5 · Cited by 43
Homma, M., Oka, K., Niitsuma, T., & Itoh, H. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03799.x · Cited by 37
Effects of Aβ25–35on neurogenesis in the adult mouse subventricular zone and dentate gyrus
Li, X., & Zuo, P. (2005) · Neurological Research · doi:10.1179/016164105x35585 · Cited by 26
Two New Withanolides from Withania somnifera
Rahman, A., Jamal, S. A., & Choudhary, M. I. (1992) · Heterocycles · doi:10.3987/com-91-5791 · Cited by 19
Cited by
Sorted by citations
An Overview on Ashwagandha: A Rasayana (Rejuvenator) of Ayurveda
Singh, N., Bhalla, M., De Jager, P., & Gilca, M. (2011) · African Journal of Traditional, Complementary and Alternative Medicines · doi:10.4314/ajtcam.v8i5s.9 · Cited by 544
Withania somnifera: an Indian ginseng
Kulkarni, S. K., & Dhir, A. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.011 · Cited by 416
Sehgal, N., Gupta, A., Valli, R. K., Joshi, S. D., Mills, J. T., Hamel, E., Khanna, P., Jain, S. C., Thakur, S. S., & Ravindranath, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112209109 · Cited by 390
Pharmacologic overview of Withania somnifera, the Indian Ginseng
Dar, N. J., Hamid, A., & Ahmad, M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2012-1 · Cited by 391
Review on Alzheimer’s Disease: Inhibition of Amyloid Beta and Tau Tangle Formation
Ashrafian, H., Zadeh, E. H., & Khan, R. H. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.11.192 · Cited by 368
Metadata
- Authors
- Kuboyama, T., Tohda, C., & Komatsu, K.
- Affiliations
- University of Toyama (JP)
- Corresponding author
- Tohda, Chihiro
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2006-03
- Volume
- 23
- Issue
- 6
- Pages
- 1417-1426
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W1841364166
- Cited by
- 171
- References
- 34
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 10 · 2023: 13 · 2022: 12 · 2021: 13 · 2020: 15 · 2019: 6 · 2018: 7 · 2017: 11 · 2016: 8 · 2015: 11 · 2014: 5 · 2013: 3 · 2012: 5
- FWCI
- 15.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- withanoside IV, amyloid beta 25-35, Alzheimer's disease, neurodegeneration, anti-dementia drugs, neurite outgrowth, axon regeneration, memory impairment, Withania somnifera, oral administration, cortical neurons
- MeSH terms
- Animals, Cerebral Cortex, Chromatography, High Pressure Liquid, Ergosterol, Immunohistochemistry, Male, Memory, Nerve Degeneration, Nerve Regeneration, Neurons, Peptide Fragments, Plant Extracts, Mass Spectrometry, Synapses, Amyloid beta-Peptides, Neurites, Rats, Sprague-Dawley, Maze Learning, Withania, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
